Understanding Glaucoma: Types, Diagnosis, and Treatment
Glaucoma encompasses a group of eye disorders characterized by damage to the optic nerve, often associated with elevated intraocular pressure (IOP), resulting in vision loss or blindness if left untreated. There are several types of glaucoma, including open-angle glaucoma, closed-angle glaucoma, normal-tension glaucoma, and secondary glaucoma. Diagnosis of glaucoma typically involves a comprehensive eye examination, including measurement of IOP, assessment of the optic nerve head, visual field testing, and evaluation of the drainage angle.
Types of Glaucoma
Open-Angle Glaucoma: This is the most common type of glaucoma, characterized by a gradual blockage of the drainage angle of the eye, leading to increased IOP and optic nerve damage.
Closed-Angle Glaucoma: This occurs when the drainage angle of the eye becomes suddenly blocked, causing a rapid increase in IOP and acute symptoms such as severe eye pain, blurred vision, and halos around lights.
Normal-Tension Glaucoma: In this subtype, optic nerve damage and visual field loss occur despite normal IOP readings, suggesting other factors may contribute to the condition.
Secondary Glaucoma: This type of glaucoma results from underlying systemic or ocular conditions, such as trauma, inflammation, or certain medications, leading to increased IOP and optic nerve damage.
Diagnosis of Glaucoma
Diagnosing glaucoma involves a series of tests conducted during a comprehensive eye examination. These tests include measurement of IOP using tonometry, examination of the optic nerve head to assess for signs of damage, visual field testing to detect peripheral vision loss, and evaluation of the drainage angle using gonioscopy. Additional imaging studies, such as optical coherence tomography (OCT) or visual field testing, may also be performed to aid in diagnosis and monitoring of disease progression.
Retyne Infrared Eye Treatment for Glaucoma
The Retyne Infrared Eye treatment mask offers a non-invasive therapeutic option for managing glaucoma symptoms and potentially slowing disease progression. Program #2 on the Retyne controller utilizes invisible infrared light therapy, which has been shown to have anti-inflammatory and vasodilatory effects. By targeting the underlying inflammation and improving ocular blood flow, infrared light therapy may help reduce IOP and protect the optic nerve from further damage in individuals with glaucoma.
Glaucoma is a progressive eye condition that requires early detection and ongoing management to preserve vision and prevent irreversible vision loss. The Retyne Infrared Eye treatment mask provides a promising adjunctive therapy for individuals with glaucoma, offering invisible infrared light therapy that may help alleviate symptoms, reduce IOP, and protect the optic nerve. When used as part of a comprehensive treatment plan, infrared light therapy has the potential to improve outcomes and enhance the quality of life for individuals living with glaucoma. Early diagnosis, regular monitoring, and appropriate intervention are essential for optimizing vision preservation in patients with glaucoma.
The Retyne eye treatment mask harnesses a series of frequencies (0.07, 0.12, 0.6, 0.87, 2.25, 22.5, 187.5, 396.5, 587.5, 696.5) specifically tailored for addressing Open-Angle Glaucoma. These frequencies have been carefully selected for their efficacy in managing and treating this condition. Retyne's approach involves translating each frequency into invisible infrared light output, representing a novel integration of frequencies with light, a pioneering technology developed by Retyne Labs.
This innovative method draws inspiration from the pioneering work of Dr. Rife, who identified specific frequencies with healing properties and utilized a light source for their transmission. Building upon current research on invisible infrared technology and leveraging past studies on light transmission via frequency sources, the Retyne eye treatment mask represents a fusion of cutting-edge advancements in the field.
Open-Angle Glaucoma General Group exists at program 1407 on the International ETDFL frequency list
Compatibility
Standalone controller (Program #2) (Controller shipped with Retyne Eye Treatment Mask)
RDPV4 (Direct connect, use group 1407)
RDPV4 Light Mask Program button 2
Click here for instructions on using the Retyne Mask + Controller
